Drugs that contain Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate

1. Drug name - OSMOPREP

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7687075 SALIX PHARMS Colonic purgative composition with soluble binding agent
Jun, 2028

(5 years from now)

CN101087593B SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

CN101087593A SALIX PHARMS Colon Cathartic Constituent Containing Dissoluble Adhesive
Nov, 2024

(2 years from now)

CN102648980A SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

CN102648980B SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

EP1682098A1 SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

EP2308476A1 SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

EP2308476B1 SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

EP1682098B1 SALIX PHARMS Colonic Purgative Composition With Soluble Binding Agent
Nov, 2024

(2 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.398GM;1.102GM TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.